Table 5.
Drug treatments most frequently reported by patients with SLEa (n=1566b posts) and CLEc (n=82b posts).
| Drug treatments | Mentions in posts, n (%) | |
|
|
SLE | CLE |
| Hydroxychloroquine | 538 (34.4) | 42 (51.2) |
| Prednisone | 322 (20.6) | 8 (9.6) |
| Methotrexate | 303 (19.3) | 29 (35.4) |
| Azathioprine | 107 (6.8) | 6 (7.3) |
| Prednisolone | 100 (6.4) | 17 (20.7) |
| Aspirin | 49 (3.1) | 1 (1.2) |
| Ibuprofen | 44 (2.8) | —d |
| Warfarin | 42 (2.7) | — |
| Paracetamol | 35 (2.2) | — |
| Quinacrine | 26 (1.7) | 7 (8.5) |
| Cyclosporine | — | 4 (4.8) |
| Tacrolimus | — | 3 (3.7) |
| Naproxen | — | 2 (2.4) |
aSLE: systemic lupus erythematosus.
bIndicates that patients were counted more than once they discussed more than one drug treatment in a post.
cCLE: cutaneous lupus erythematosus.
dNot available.